AMANDA WENDENBURG: Open Payments
NPI 1063083566 · RAEFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,926 in 100 payments from 18 companies in 2025. Trend: 2023 $1,919 · 2024 $2,300 · 2025 $1,926
Food & beverage: $1,926
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $296 |
| AstraZeneca Pharmaceuticals LP | 10 | $290 |
| Novo Nordisk Inc | 15 | $224 |
| Almatica Pharma LLC | 9 | $201 |
| ABBVIE INC. | 11 | $190 |
| Exact Sciences Corporation | 9 | $139 |
| PFIZER INC. | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $106 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| SHIELD THERAPEUTICS INC | 2 | $50 |
Products named: JARDIANCE, LOREEV XR, FARXIGA, VRAYLAR, BREZTRI, Ozempic, Wegovy, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
